Stevanato Group Announces Voting Results from its Extraordinary General Meeting
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announced today that the resolution proposed to shareholders at the Extraordinary General Meeting of Shareholders (“EGM”) held virtually on October 4, 2023 was passed.
- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries announced today that the resolution proposed to shareholders at the Extraordinary General Meeting of Shareholders (“EGM”) held virtually on October 4, 2023 was passed.
- Details of the resolution submitted to, and approved by, the EGM are included in the explanatory report prepared by the Board of Directors of the Company, which is available on the Company’s corporate website at https://ir.stevanatogroup.com/shareholders-meetings .
- Further information regarding the EGM is available on Stevanato Group’s corporate website at https://ir.stevanatogroup.com/shareholders-meetings , including the full text of the EGM notice, explanatory report and other EGM materials.
- Shareholders may request a hard copy of EGM materials, free of charge, by emailing [email protected] .